Tempus is a technology company that is building the world's largest library of molecular and clinical data and an operating system to make that data accessible and useful.
Our approach utilizes genomic and transcriptomic sequencing in our lab and deep machine learning to help doctors obtain a better understanding of each patient's tumor.
Our platform allows physicians to analyze molecular data along with clinical data to uncover more personalized treatment options.
We deliver a detailed report to a patient's physician that highlights actionable insights and their implications for a patient's treatment.
In collaboration with physicians and researchers, we develop novel automation and cell-culture technology, which allows screening of therapies to occur in synthetic and animal models, instead of patients.